Loading...
Chemical structure of PD-1/PD-L1 Inhibitor 3

GC16258

PD-1/PD-L1 Inhibitor 3

Also known as N,3-bis(2-amino-2-oxoethyl)-9-benzyl-21,24-dibutyl-18-(3-carbamimidamidopropyl)-30-(hydroxymethyl)-42-(1H-imidazol-5-ylmethyl)-27,33-bis(1H-indol-3-ylmethyl)-6,7,22,25,37-pentamethyl-39-(2-methylpropyl)-2,5,8,11,17,20,23,26,29,32,35,38,41,44-tetradecaoxo-13-thia-1,4,7,10,16,19,22,25,28,31,34,37,40,43-tetradecazabicyclo[43.3.0]octatetracontane-15-carboxamide

PD-1/PD-L1 Inhibitor 3, a macrocyclic peptide, is a potent and selective inhibitor of the PD-1/PD-L1 and CD80/PD-L1 interactions extracted from patent WO2014151634A1, compound No·1· PD-1/PD-L1 Inhibitor 3 interferes with PD-L1 binding to PD-1 and CD80 by binding to PD-L1, with IC50s of 5·60 nM and 7·04 nM, respectively· PD-1/PD-L1 Inhibitor 3 can be used for the research of various diseases, including cancer and infectious diseases

ChemicalCAS1629654-95-0MW1852.17FormulaC89H126N24O18S
CAS number
1629654-95-0
Molecular weight
1852.17
Formula
C89H126N24O18S
Solubility
Soluble in DMSO
InChIKey
XAUDCIZFSQEZFS-UHFFFAOYSA-N
Catalogue number
GC16258
Brand
GLPBIO
Computed properties PubChem CID 123453538 · XLogP 1.8 · TPSA 646 Ų · H-bond donors 19
XLogP
1.8
TPSA
646 Ų
H-bond donors
19
H-bond acceptors
21
Rotatable bonds
27
Heavy atoms
132

SMILES CCCCC1C(=O)NC(C(=O)NC(CSCC(=O)NC(C(=O)N(C(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)NC(C(=O)N(CC(=O)NC(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N1C)CCCC)C)CC3=CNC4=CC=CC=C43)CO)CC5=CNC6=CC=CC=C65)C)CC(C)C)CC7=CN=CN7)CC(=O)N)C)C)CC8=CC=CC=C8)C(=O)NCC(=O)N)CCCNC(=N)N

Computed descriptors from PubChem (CID 123453538), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.